Editorial: is ribavirin needed in the treatment of post-transplant hepatitis C recurrence?

Aliment Pharmacol Ther. 2017 Jul;46(2):197-198. doi: 10.1111/apt.14110.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents
  • Drug Therapy, Combination
  • Hepacivirus*
  • Hepatitis C
  • Humans
  • Interferon-alpha
  • Liver Transplantation
  • Recombinant Proteins
  • Recurrence
  • Ribavirin*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin